Related Experiment Video

Updated: Aug 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4

Anny Kretschmer1, Kristin Moepert, Sibylle Dames

  • 1atugen AG, Robert-Roessle-Strasse 10, Otto Warburg Hause (No 80), Berlin 13125, Germany.

Oncogene
|October 14, 2003
PubMed

Insights

Transforming growth factor-beta (TGF-β) inhibits cell growth via Smad transcription factors. Smad3 plays a predominant role in mediating this TGF-β effect on keratinocyte growth and gene expression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Smad transcription factors are key mediators of transforming growth factor-beta (TGF-β) signaling.
  • Dysregulation of Smad proteins is linked to impaired TGF-β responsiveness and various diseases.

Purpose of the Study:

  • To investigate the specific roles of individual Smad proteins (Smad2, Smad3, Smad4) in TGF-β-induced growth inhibition and gene expression.
  • To compare the contribution of each Smad in isogenic cellular backgrounds.

Main Methods:

  • Selective inhibition of Smad2, Smad3, and Smad4 expression using antisense molecules in HaCaT keratinocytes.
  • Assessment of TGF-β-mediated cell growth inhibition and cell cycle arrest.
  • Gene expression profiling to identify differentially regulated genes.

Main Results:

  • Smad3 was identified as the predominant mediator of TGF-β's growth inhibitory effects on HaCaT keratinocytes.
  • Inhibition of Smad3 significantly impacted TGF-β-induced cell cycle arrest and regulation of cell cycle genes.
  • Smad4 inhibition showed a partial effect, while Smad2 inhibition had no significant impact on TGF-β responses.
  • Gene expression profiling revealed distinct roles for Smad2 and Smad3 in regulating TGF-β-dependent genes.

Conclusions:

  • Smad3 plays a critical role in mediating TGF-β-induced growth inhibition and gene expression in keratinocytes.
  • Smad2, Smad3, and Smad4 contribute differentially to TGF-β signaling pathways.
  • The specific roles of Smads in TGF-β responses can vary depending on the cell type.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...